Barrier, Hydration and Topical Lifting: The HA Line by Armonita Laboratoires for Professional Post-Procedural Care
Every ablative or minimally invasive treatment opens a critical biological phase in which the skin must reorganize its structures. The quality of this phase, often referred to as recovery, significantly determines the duration and intensity of the aesthetic result achieved with the procedure. Yet in clinical practice, topical post-procedural management is still often entrusted to generic products or unstructured protocols that fail to account for the complexity of the mechanisms at play.
Armonita Laboratoires has developed two complementary formulations to address this need in a scientific and differentiated way: HA Regenerating Cream, focused on restoring the epidermal barrier in post-ablative phases, and HA Serum, designed for deep multi-molecular hydration in the context of post-filler care and maintenance. Distinct products in terms of mechanisms of action and application contexts, but united by a formulative rationale based on hyaluronic acid and an exclusively professional positioning.
BIOLOGICAL AND FUNCTIONAL PROBLEM OVERVIEW
Hyaluronic acid (HA) is the most abundant glycosaminoglycan in the cutaneous extracellular matrix. With a differential distribution between the dermis (approximately 0.5 mg/g of tissue) and the epidermis (approximately 0.1 mg/g), it performs functions of tissue hydration, structural support and cell signaling. Its turnover is rapid: its half-life in the skin is measured in hours, making the tissue particularly vulnerable to any factor that accelerates its degradation.
Ablative procedures, through heat or chemical action, trigger an inflammatory cascade that includes the production of reactive oxygen species (ROS), which degrade HA chains into low-molecular-weight fragments and compromise the intercorneocyte lipid film. The result is increased transepidermal water loss (TEWL), persistent erythema and vulnerability to external agents.
In the context of filler treatment, the issue is different but related: the cross-linked HA injected works in the deep dermis, but the superficial skin overlying it also undergoes a local inflammatory response and a reduction in epidermal hydration. This inhomogeneity between depth and surface can limit the visual rendering of the aesthetic result. With advancing age, the progressive reduction of endogenous HA makes this imbalance even more pronounced.
SCIENTIFIC EVIDENCE SUPPORTING THE APPROACH
In a review published in SKINmed (Keen, 2017), it was documented that topical hyaluronic acid is able to restore epidermal hydration and improve skin elasticity. High-molecular-weight HA forms a protective film on the surface, limiting TEWL, while low-molecular-weight fractions (e.g., 50 kDa) penetrate into the deeper layers of the epidermis, interacting with the CD44 receptor at the basal level.
The same review highlights the role of HA in maintaining a moist environment favorable to healing, in stimulating growth factors and in protecting tissue from ROS thanks to the action of high-molecular-weight chains. Clinical studies have documented the topical use of HA in tissue repair contexts (burns, ulcers) with a good safety and tolerability profile. In the literature it has been observed that the combination of different molecular fractions in a single formulation can optimize coverage of the various skin levels compared to the use of a single molecular weight.
THE FORMULATIVE RATIONALE OF THE ARMONITA HA LINE
The two formulations share hyaluronic acid as the central ingredient but differ in formulative strategy, calibrated on the application context of each.
HA Regenerating Cream — post-ablative barrier restoration
HA Regenerating Cream integrates an active moisturizing system with specific ingredients for restoring the epidermal barrier. The formulative approach covers three levels of intervention:
- Hyaluronic Acid + Exo-H + Hydrosella: multi-level moisturizing system for cellular and tissue water retention in the hours and days following the procedure
- Ceramide 3 + IBR-Urbiotect: restoration of the intercorneocyte lipid film and integrity of the compromised epidermal barrier
- Niacinamide: promotes the synthesis of endogenous ceramides, anti-inflammatory action and may contribute to the reduction of post-procedural erythema
- Shea Butter, Cocoa Butter, Argan Oil, Jojoba Oil: basic occlusive support that limits TEWL in the early stages of recovery
- Skinectura + Bromelain: remodeling of the extracellular matrix and modulation of the local inflammatory response
- Triopherol® + Corneopeptyl: antioxidant protection and support for corneocyte differentiation for normalization of epidermal architecture
HA Serum — post-filler multi-molecular hydration
HA Serum is built around a multi-molecular hyaluronic acid system designed to work in synergy with the filler result. Each component covers a specific level of action:
- Hyacare 50 (50 kDa): penetrates the deep epidermal layers, reaches basal cells and interacts with the CD44 receptor
- Xilogel HS: distribution of HA in tissues and progressive tensioning action, contributes to the topical lifting effect
- Glycotensyl: film-forming agent with immediate tensioning effect, optimizes visual compactness and amplifies the perception of lifting
- D-Panthenol: supports re-epithelialization and reduces the sensation of local irritation post-injection
- Nicotinamide: ceramide synthesis, anti-inflammatory action and contribution to the control of post-inflammatory hyperpigmentation
- BiPure: antioxidant protection against oxidative stress induced by the procedure
ARMONITA LABORATOIRES: THE VALUE OF THE PROFESSIONAL LINE
The HA Armonita line is the result of the synergy between the scientific research of Gruppo Farmaimpresa and professional cosmetic formulation. Each product is developed with ingredients selected for formulative stability and documented bioavailability, with particular attention to the compatibility of active ingredients in post-procedural skin conditions, where tissue permeability is significantly altered compared to normal.
The positioning of the line is exclusively professional: distribution through selected channels, dedicated technical support for aesthetic medicine clinics and medical aesthetic centers, availability of private label with regulatory documentation for EU markets. Those seeking a production partner to develop their own post-procedural line find in Armonita Laboratoires a reference with high standards applied to cosmetics.
If your company is interested in Armonita Collections:
Source: Keen MA. Hyaluronic Acid in Dermatology. SKINmed. 2017;15(6):462-469.
